BamSEC and AlphaSense Join Forces
Learn More

Atherogenics Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 34 pages Asset Purchase Agreement by and Between Crabtree Acquisition Co, LLC, Atherogenics, Inc. and King & Spalding Llp March 17, 2009
12/34/56
EX-10.1
from 10-Q 67 pages This Document Have Been Redacted and Have Been Filed Separately With the U.S. Securities and Exchange Commission Atherogenics, Inc., a Georgia Corporation (“Agix”) and Isp Pharma Systems LLC, a Delaware Limited Liability Company (“Isp”) Manufacturing and Supply Agreement Dated as of April 1, 2008 Manufacturing and Supply Agreement
12/34/56
EX-10.26
from 10-K 21 pages Amended Employment Agreement
12/34/56
EX-10.25
from 10-K 21 pages Amended Employment Agreement
12/34/56
EX-10.24
from 10-K 22 pages Amended Employment Agreement
12/34/56
EX-10.23
from 10-K 21 pages Amended Employment Agreement
12/34/56
EX-10.5
from 8-K 20 pages Employment Agreement
12/34/56
EX-10.4
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.3
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 20 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 20 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 11 pages Indemnification Agreement
12/34/56
EX-10.37
from 10-K ~20 pages Ex-10.37 Transition Services Agreement
12/34/56
EX-10.36
from 10-K ~50 pages Ex-10.36 Co-Promotion Agreement
12/34/56
EX-10.35
from 10-K >50 pages Ex-10.35 License and Collaboration Agreement
12/34/56
EX-10.34
from 10-K ~50 pages Ex-10.34 Commercial Supply Agreement
12/34/56
EX-10.02
from 8-K ~5 pages Ex-10.02 Atherogenics, Inc. 2004 Equity Ownership Plan
12/34/56
EX-10.1
from 10-Q 4 pages First Amendment to the License Agreement Between Emory University and Atherogenics 1
12/34/56
EX-10.1
from 8-K 4 pages Transition Agreement
12/34/56
EX-10.1
from 8-K 21 pages Employment Agreement
12/34/56